Framingham Heart Study Gutted

The iconic Framingham Heart Study, the longest-running cardiovascular study in the country, has been hit with a $4 million budget cut.

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

WIKIMEDIA, HEIKENWAELDER HUGOThe 65-year-old Framingham Heart Study, which has studied the causes and effects of cardiovascular disease, is faced with $4 million in budget cuts due to sequestration. The cuts mean 19 of the 90 study staff members will lose their jobs, the Huffington Post reported. In addition, the cuts could mean that the next round of testing, to be conducted over the next two to three years, could be threatened.

“You’re going to lose a major investment that we’ve been making over the last 65 years,” Karen Antman, dean of Boston University School of Medicine, which co-runs the Framingham Heart Study, told the Huffington Post. “This is an iconic trial that has more than proven its value from a public health point of view.”

In 1948, the Framingham study began with funding from the National Heart, Lung and Blood Institute (NHLBI), a division of the National Institutes of Health (NIH). Over the years, the cohort study has recruited more than 15,000 residents of Framingham, Mass., across three generations to help identify risk factors for diabetes, hypertension, hyperlipidemia, and other cardiovascular diseases. The Framingham study receives around $21 million in funding from the NIH annually, about ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Chris Palmer

    This person does not yet have a bio.
Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo
Characterizing Immune Memory to COVID-19 Vaccination

Characterizing Immune Memory to COVID-19 Vaccination

10X Genomics

Products

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours

iStock

Agilent BioTek Cytation C10 Confocal Imaging Reader

agilent technologies logo